´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10 |
|
´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ IASS 2023 (Çмú´ëȸ) : 2023-05-10 ±³À°ÁÖÁ¦ : IASS 2023 (Çмú´ëȸ) ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ´ã´çÀÚ : ÃÖ°æ¼ö À̸ÞÀÏ : IASS2022@humming.co.kr ±³À°Á¾·ù : ÇǺΰú Âü¼®¿¹»óÀÎ : 300¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 500,000¿ø ºñ°í ÇǺΰú Àü¹®ÀÇ : 5¸¸¿ø·¹Áö´øÆ®, ¿¬±¸¿ø : 2¸¸¿øºñȸ¿ø : 50¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:20~09:40 What¡¯s new in itch mechanism and therapeutic approaches for atopic dermatitis? Jiehyun Jeon(Korea Univ.) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 09:40~10:00 Characteristics for pediatric atopic dermatitis : What¡¯s the different adult atopic dermatitis? Sang Eun Lee(Yonsei Univ.) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:00~10:20 Understanding of skin microbiome in atopic dermatitis for advance atopic dermatitis treatment Jihyun Lee(Catholic Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:20~10:30 Q&A ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 10:30~11:10 Introduction of the concept of minimal disease activity Mark Kirchhof(Ottawa Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:10~11:20 Q&A ( ) ÈÞ½Ä 05¿ù 10ÀÏ 11:20~11:35 Coffee Break ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 11:35~12:15 Can treatment impact the natural course of atopic dermatitis and comorbidity? Eric simpson(Oregon Health and Science Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:15~12:25 Q&A ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:25~12:45 Prominent role of type 2 inflammation in skin diseases: beyond atopic dermatitis (Jiyoung Ahn) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 12:45~12:55 Q&A ( ) ½Ä»ç 05¿ù 10ÀÏ 12:55~13:20 Lunch ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 13:20~14:00 Current learning on the applications of atopic dermatitis therapy in real-world practice Stephan Weidinger(Christian-Albrechts Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:00~14:10 Q&A ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:10~14:50 How does baricitinib real-world evidence compare to randomized controlled trials? Andreas Wollenberg(Ludwig-Maximilian Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 14:50~15:00 Q&A ( ) ÈÞ½Ä 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:00~15:15 Coffee Break ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:15~15:55 Long-term perspectives in atopic dermatitis Chih-Ho Hong(British Columbia Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 15:55~16:05 Q&A ( ) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:05~16:25 Treat-to-target in atopic dermatitis : an important strategy for successful treatment Chan Ho Na(Chosun Univ.) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:25~16:45 Optimal use of JAK inhibitors for atopic dermatitis based on real-world experiences Min Kyung Shin(Kyung Hee Univ.) ±³À°½Ã°£ 05¿ù 10ÀÏ ±×·£µåº¼·ë 16:45~17:05 Update on the treatment of pediatric atopic dermatitis Jung-Im Na(Seoul National Univ.) Åä·Ð 05¿ù 10ÀÏ ±×·£µåº¼·ë 17:05~17:15 Q&A ( )
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|